Publicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (126)

2024

  1. Comment on the article: In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model

    Pharmaceutical Research

  2. Correction to: Comment on the article: In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model (Pharmaceutical Research, (2024), 41, 8, (1595-1597), 10.1007/s11095-024-03729-8)

    Pharmaceutical Research

  3. Effects of Minimalist vs. Traditional Running Shoes on Abdominal Lumbopelvic Muscle Activity in Women Running at Different Speeds: A Randomized Cross-Over Clinical Trial

    Sensors, Vol. 24, Núm. 2

2023

  1. Differences between Novice and Expert Raters Assessing Trunk Control Using the Trunk Control Measurement Scale Spanish Version (TCMS-S) in Children with Cerebral Palsy

    Journal of Clinical Medicine, Vol. 12, Núm. 10

2019

  1. Evaluating the optimal time for amikacin administration with respect to haemodialysis using an in vitro pharmacodynamic simulation against epidemic nosocomial OXA-48 producing Klebsiella pneumoniae ST405 strains

    Journal of Global Antimicrobial Resistance, Vol. 19, pp. 241-251

2014

  1. Análisis de 38 casos de traqueobronquitis en pacientes inmunocompetentes con doble aislamiento de Aspergillus en muestras de tracto respiratorio inferior

    Revista Espanola de Quimioterapia, Vol. 27, Núm. 2, pp. 110-114

  2. Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 6, pp. 1624-1632

2013

  1. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 10, pp. 2291-2295

  2. Protection of Enterococcus faecalis in mixed cultures with carbapenemase-producing Escherichia coli and Bacteroide fragilis: effect of the bacterial load.

    Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia, Vol. 26, Núm. 3, pp. 220-225

2012

  1. Cefditoren and Ceftriaxone Enhance Complement-Mediated Immunity in the Presence of Specific Antibodies against Antibiotic-Resistant Pneumococcal Strains

    PLoS ONE, Vol. 7, Núm. 9

  2. Clinical features of invasive pulmonary aspergillosis vs. colonization in COPD patients distributed by gold stage

    Journal of Infection, Vol. 65, Núm. 5, pp. 447-452

  3. Comparative in vitro activity of common antibiotics and relationship with changes in Streptococcus pneumoniae serotypes causing otitis in children prior to and 10 years after introduction of conjugate vaccines in Spain

    International Journal of Antimicrobial Agents

  4. Correlation between clinical parameters characterising peri-implant and periodontal health: A practice-based research in Spain in a series of patients with implants installed 4-5 years ago

    Medicina Oral, Patologia Oral y Cirugia Bucal, Vol. 17, Núm. 5

  5. In vitro interference of tigecycline at subinhibitory concentrations on biofilm development by Enterococcus faecalis

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1155-1158

  6. Macrolides and β-lactam antibiotics enhance C3b deposition on the surface of multidrug-resistant Streptococcus pneumoniae strains by a LytA autolysin-dependent mechanism

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 11, pp. 5534-5540

  7. Repeated Aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: Colonisation or infection?

    BMC Infectious Diseases, Vol. 12

  8. Update on the clinical utility and optimal use of cefditoren

    International Journal of General Medicine, Vol. 5, pp. 455-464

  9. Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000-May 2001) and 10 years after (May 2010-May 2011) introduction of conjugate vaccines for child immunisation in Spain

    International Journal of Antimicrobial Agents, Vol. 40, Núm. 1, pp. 18-23

2011

  1. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24 h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate- resistant Staphylococcus aureus

    International Journal of Antimicrobial Agents, Vol. 37, Núm. 4, pp. 332-338

  2. Bacterial clearance from blood in mice infected by S. pneumoniae (penicillin MIC=16 mu g/ml) presenting specific IgG (non-protective levels) and treated with sub-therapeutic regimens of cefditoren (a highly bound cephalosporin)

    SCIENCE AND TECHNOLOGY AGAINST MICROBIAL PATHOGENS: RESEARCH, DEVELOPMENT AND EVALUATION